Safety and Tolerability of Tolvaptan in an Autosomal Dominant Polycystic Kidney Disease Spanish Cohort: A Real-World Experience

Introduction: Autosomal dominant polycystic kidney disease (ADPKD) is the commonest inherited disorder of the kidneys. A vasopressin V2-receptor antagonist (tolvaptan) was recently approved for the treatment of ADPKD. This study aims to analyze the safety and tolerability of tolvaptan for the manage...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cureus
Main Authors: Guerra-Torres, Xavier E, Peña Esparragoza, J, Perez Fernandez, M, Fernandez Rodríguez, M, Mancha Ramos, J, Martinez Miguel, P, Rodriguez Puyol, D, Bouarich, H
Formato: Artigo
Idioma:Inglês
Publicado: Cureus 2020
Assuntos:
Internal Medicine
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7532866/
https://ncbi.nlm.nih.gov/pubmed/33033683
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.10207
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares